PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann, Joshua A. Bauer, Johanna M. Schafer, Christopher S. Pendleton, Luojia Tang, Kimberly C. Johnson, Xi Chen, Justin M. Balko, Henry Gómez, Carlos L. Arteaga, Gordon B. Mills, Melinda E. Sanders, Jennifer A. Pietenpol
Dive into the research topics of 'PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors'. Together they form a unique fingerprint.